AI assistant
Sending…
Alaunos Therapeutics, Inc. — Director's Dealing 2021
Feb 26, 2021
35407_dirs_2021-02-26_226d1847-a455-42ea-acc1-bb38f6c28ece.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: ZIOPHARM ONCOLOGY INC (ZIOP)
CIK: 0001107421
Period of Report: 2021-02-17
Reporting Person: Cunningham Timothy M. (interim CFO)
More from Alaunos Therapeutics, Inc.
Regulatory Filings
2026
May 26
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 15
Delisting Announcement
2026
Apr 15
Annual Report
2026
Mar 31
Regulatory Filings
2026
Mar 2
Director's Dealing
2026
Jan 15
Director's Dealing
2026
Jan 15
Director's Dealing
2026
Jan 15
Regulatory Filings
2026
Jan 8